Your Article Summary
Identification and profiling of circulating metabolites of atazanavir, a human immunodeficiency virus protease inhibitor
Drug Metabolism and Disposition, 07/01/09
Heine RT et al. - Atazanavir metabolite levels were positively correlated with atazanavir levels, but inter-individual variability was high. The developed atazanavir metabolic screening method can now be used for further clinical pharmacological research with this antiretroviral agent.
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09
Inflammatory breast cancer: what are the treatment options
Expert Opinion in Pharmacotherapy, 12/08/09
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
Expert Opinion on Investigational Drugs, 12/08/09

See Latest Articles